GN executive: ”We fear neither Trump nor Brexit”

A forthcoming Brexit, extra taxes on medical devices, OTC markets, and an unruly Donald Trump – it all creates political and regulatory uncertainty. However, it does not discourage CEO in GN Hearing, Anders Hedegaard. “We are well placed to deliver,” he says.

Photo: GN Resound, PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Lundbeck på FDA's sorte liste: Vi forstår det ikke

De amerikanske sundhedsmyndigheder har offentliggjort en liste med selskaber, der kan have benyttet sig af tvivlsomme taktikker for at forsinke generisk konkurrence. Lundbeck er blandt dem, men det er helt forfejlet, siger selskabets pressechef.

Related articles